{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:49:29Z","timestamp":1763563769867,"version":"3.38.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4,1]]},"DOI":"10.2146\/ajhp100243","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T23:53:17Z","timestamp":1300319597000},"page":"590-598","source":"Crossref","is-referenced-by-count":7,"title":["Effect of loading dose and formulation on safety and efficacy of conivaptan in treatment of euvolemic and hypervolemic hyponatremia"],"prefix":"10.1093","volume":"68","author":[{"given":"Sanjay","family":"Kalra","sequence":"first","affiliation":[{"name":"Bharti Hospital and Bharti Research Institute of Diabetes and Endocrinology, Karnal, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shai","family":"Efrati","sequence":"additional","affiliation":[{"name":"Research and Development Unit, Assaf-Harofeh Medical Center, Zerifin, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Arthur","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Medical University of South Carolina (MUSC), Charleston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arie","family":"Oliven","sequence":"additional","affiliation":[{"name":"Bnai-Zion Medical Center, Haifa, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos Q.","family":"Velez","sequence":"additional","affiliation":[{"name":"Division of Nephrology, MUSC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce E.","family":"McNutt","sequence":"additional","affiliation":[{"name":"Astellas Pharma US, Inc., Deerfield, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Klasen","sequence":"additional","affiliation":[{"name":"Astellas Pharma US, Inc., Deerfield, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anura","family":"Abeyratne","sequence":"additional","affiliation":[{"name":"Astellas Pharma US, Inc., Deerfield, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041105535051500_b1-0680590","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0008-6363(01)00315-7","article-title":"Vasopressin V2 receptor antagonists","volume":"51","author":"Wong","year":"2001","journal-title":"Cardiovasc Res."},{"issue":"(suppl 1)","key":"key\n\t\t\t\t2019041105535051500_b2-0680590","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.amjmed.2006.05.005","article-title":"Incidence and prevalence of hyponatremia","volume":"119","author":"Upadhyay","year":"2006","journal-title":"Am J Med."},{"issue":"(suppl 1)","key":"key\n\t\t\t\t2019041105535051500_b3-0680590","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2007.09.001","article-title":"Hyponatremia treatment guidelines 2007: expert panel recommendations","volume":"120","author":"Verbalis","year":"2007","journal-title":"Am J Med."},{"issue":"(suppl 1)","key":"key\n\t\t\t\t2019041105535051500_b4-0680590","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.amjmed.2006.05.006","article-title":"Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis","volume":"119","author":"Robertson","year":"2006","journal-title":"Am J Med."},{"key":"key\n\t\t\t\t2019041105535051500_b5-0680590","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0889-8529(05)70207-3","article-title":"Antidiuretic hormone. Normal and disordered function","volume":"30","author":"Robertson","year":"2001","journal-title":"Endocrinol Metab Clin North Am."},{"key":"key\n\t\t\t\t2019041105535051500_b6-0680590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/jme.0.0290001","article-title":"Vasopressin V2 receptor antagonists","volume":"29","author":"Verbalis","year":"2002","journal-title":"J Mol Endocrinol."},{"key":"key\n\t\t\t\t2019041105535051500_b7-0680590","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7326\/0003-4819-102-2-164","article-title":"Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin","volume":"102","author":"Anderson","year":"1985","journal-title":"Ann Intern Med."},{"key":"key\n\t\t\t\t2019041105535051500_b8-0680590","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/0002-9343(67)90096-4","article-title":"The syndrome of inappropriate secretion of antidiuretic hormone","volume":"42","author":"Bartter","year":"1967","journal-title":"Am J Med."},{"key":"key\n\t\t\t\t2019041105535051500_b9-0680590","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0002-9343(57)90224-3","article-title":"A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone","volume":"23","author":"Schwartz","year":"1957","journal-title":"Am J Med."},{"key":"key\n\t\t\t\t2019041105535051500_b10-0680590","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/ncpneph0401","article-title":"Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists","volume":"3","author":"Chen","year":"2007","journal-title":"Nat Clin Pract Nephrol."},{"key":"key\n\t\t\t\t2019041105535051500_b11-0680590","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0002-9149(86)90065-2","article-title":"Arginine vasopressin and the renal response to water loading in congestive heart failure","volume":"58","author":"Goldsmith","year":"1986","journal-title":"Am J Cardiol."},{"key":"key\n\t\t\t\t2019041105535051500_b12-0680590","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0889-8529(03)00004-5","article-title":"Evaluation and management of hypo-osmolality in hospitalized patients","volume":"32","author":"Janicic","year":"2003","journal-title":"Endocrinol Metab Clin North Am."},{"key":"key\n\t\t\t\t2019041105535051500_b13-0680590","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0014-2999(96)00940-5","article-title":"Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V1A and V2 receptor antagonist in dogs","volume":"321","author":"Yatsu","year":"1997","journal-title":"Eur J Pharmacol."},{"key":"key\n\t\t\t\t2019041105535051500_b14-0680590","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0022-3565(24)36784-9","article-title":"Pharmacological profile of YM087, a novel potent nonpeptide vasopressin V1A and V2 receptor antagonist, in vitro and in vivo","volume":"282","author":"Tahara","year":"1997","journal-title":"J Pharmacol Exp Ther."},{"key":"key\n\t\t\t\t2019041105535051500_b15-0680590","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1210\/jc.2005-2287","article-title":"Efficacy and safety of oral conivaptan: a V1A\/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia","volume":"91","author":"Ghali","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"key\n\t\t\t\t2019041105535051500_b16-0680590","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000106456","article-title":"Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia","volume":"27","author":"Zeltser","year":"2007","journal-title":"Am J Nephrol."},{"key":"key\n\t\t\t\t2019041105535051500_b17-0680590","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MAJ.0b013e31817b8148","article-title":"Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia","volume":"337","author":"Annane","year":"2009","journal-title":"Am J Med Sci."},{"key":"key\n\t\t\t\t2019041105535051500_b18-0680590","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2265.2007.03149.x","article-title":"Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: subgroup analysis of a randomized, controlled study","volume":"69","author":"Verbalis","year":"2008","journal-title":"Clin Endocrinol."},{"volume-title":"Vaprisol (conivaptan hydrochloride injection) package insert","year":"2008","key":"key\n\t\t\t\t2019041105535051500_b19-0680590"},{"key":"key\n\t\t\t\t2019041105535051500_b20-0680590","doi-asserted-by":"crossref","first-page":"A64","DOI":"10.1097\/00003246-200612002-00223","article-title":"Conivaptan for the treatment of hyponatremia in hospitalized patients: results from an open-label study","volume":"34","author":"Verbalis","year":"2006","journal-title":"Crit Care Med."},{"issue":"(suppl)","key":"key\n\t\t\t\t2019041105535051500_b21-0680590","first-page":"S1","article-title":"Infusion nursing standards of practice","volume":"29","author":"Infusion Nurses Society","year":"2006","journal-title":"J Infus Nurs."},{"key":"key\n\t\t\t\t2019041105535051500_b22-0680590","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2146\/ajhp040300","article-title":"Treatment of electrolyte disorders in adult patients in the intensive care unit","volume":"62","author":"Kraft","year":"2005","journal-title":"Am J Health-Syst Pharm."},{"key":"key\n\t\t\t\t2019041105535051500_b23-0680590","first-page":"905","article-title":"Severe hyponatremia: complications and treatment","volume":"88","author":"Ellis","year":"1995","journal-title":"QJM."},{"key":"key\n\t\t\t\t2019041105535051500_b24-0680590","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM200005253422107","article-title":"Hyponatremia","volume":"342","author":"Adrogu\u00e9","year":"2000","journal-title":"N Engl J Med."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/68\/7\/590\/28349222\/ajhp0590.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T15:42:25Z","timestamp":1741102945000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/68\/7\/590\/5129729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,1]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,4,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp100243","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"type":"print","value":"1079-2082"},{"type":"electronic","value":"1535-2900"}],"subject":[],"published-other":{"date-parts":[[2011,4,1]]},"published":{"date-parts":[[2011,4,1]]}}}